Exhibit 99.1 iCAD Reports Financial Results for First Quarter Ended March 31, 2024 NASHUA, N.H. – May 15, 2024 – iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2024. First Quarter 2024 Highlights (Year over Year Performance): ● Total ARR was $9.0 million, up 10% ● Total revenues were $5.0 million, up 14% ● ...